Select Page

Advanced Urology Associates

News and Announcements

UroLift® Procedure For Enlarged Prostate Surpasses Medications

By the time they’re in their sixties, approximately 70% of men in the U.S. will have an enlarged prostate, also referred to as benign prostatic hyperplasia (BPH). One very effective treatment for BPH is the UroLift® System, a procedure that lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. This is done without cutting, heating, or removing any prostate tissue.

“UroLift provides a minimally invasive alternative to medications, and provides quick and long-lasting improvement for patients with voiding symptoms associated with an enlarged prostate,” said Dr. Thomas Burns, Urologist with Advanced Urology Associates. “The procedure offers several advantages over other surgical treatment options; it can be performed safely in our office, and it does not affect a patient’s sexual function.”

The UroLift procedure is a terrific option for men looking to get off of their prostate medications, or for patients with worsening symptoms despite the use of prostate medications. “The procedure is very quick and safe, with lower surgical risks compared to other prostate surgeries,” added Dr. Burns. “Since this treatment is a minimally invasive outpatient procedure, most men experience a quick recovery and will notice improved symptoms within two weeks of the procedure.” Endoscopic results can be immediately confirmed post-procedure, and the UroLift treatment does not preclude the option for future UroLift or laser procedures should they become necessary.

Advanced Urology Associates is one of the few urology practices that can provide this procedure in the office with no need for a hospital admission. “AUA is unique, as we’ve been designated as a BPH Center Of Excellence for the UroLift procedure,” said Dr. Burns. “We have been performing this relatively new procedure for the last four years or so.”

Click here for more information about the UroLift procedure.